Adaptimmune Gets the Green Light for its New T-cell Cancer Therapy – Labiotech.eu (blog)
Labiotech.eu (blog) |
Adaptimmune Gets the Green Light for its New T–cell Cancer Therapy
Labiotech.eu (blog) T-cells can have trouble detecting cancer cells, but Adaptimmune engineers them to increase their affinity by producing new sequences in the complementarity determining regions (CDRs). These share similarities with CAR–T cells, which are genetically … Adaptimmune Announces Positive Safety Data from Pilot Studies with MAGE-A10 SPEAR T–cells and First Patient to … |
